-
Trial Shows RG6206 Safe for Treating Boys with DMD
Results from a Phase 1b/2 trial of RG6206 (BMS-986089) in boys with Duchenne muscular dystrophy (DMD) suggests the medication is safe for use. Click here to learn more.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.